Search by Drug Name or NDC

    NDC 00456-1202-04 Linzess 290 ug/1 Details

    Linzess 290 ug/1

    Linzess is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is LINACLOTIDE.

    Product Information

    NDC 00456-1202
    Product ID 0456-1202_e471953e-5cf7-45b5-ae6f-e6e8a75087ea
    Associated GPIs 52557050000140
    GCN Sequence Number 069923
    GCN Sequence Number Description linaclotide CAPSULE 290 MCG ORAL
    HIC3 D6G
    HIC3 Description IBS-C/CIC AGENTS, GUANYLATE CYCLASE-C AGONIST
    GCN 33188
    HICL Sequence Number 039583
    HICL Sequence Number Description LINACLOTIDE
    Brand/Generic Brand
    Proprietary Name Linzess
    Proprietary Name Suffix n/a
    Non-Proprietary Name linaclotide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, GELATIN COATED
    Route ORAL
    Active Ingredient Strength 290
    Active Ingredient Units ug/1
    Substance Name LINACLOTIDE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202811
    Listing Certified Through 2024-12-31

    Package

    NDC 00456-1202-04 (00456120204)

    NDC Package Code 0456-1202-04
    Billing NDC 00456120204
    Package 1 BOTTLE in 1 CARTON (0456-1202-04) / 4 CAPSULE, GELATIN COATED in 1 BOTTLE
    Marketing Start Date 2012-09-08
    NDC Exclude Flag N
    Pricing Information N/A